JP Morgan analyst Arun Jayaram expressed views on ConocoPhillips (NYSE:COP) fourth-quarter results reported today. The ...

Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

Yet, while Marvel basks in the glow of Critics Choice Awards’ golden glow, drumming up triumph for its summer spectacle, ...

Phil Johnson started about four months ago as chief commercial officer at Evidation. He sat down on the sidelines of JP ...

Analysts at JP Morgan and BMO Capital Markets downgraded Air Products and Chemicals Inc (NYSE:APD) on concerns over earnings growth, currency headwinds, and management transition.

George Gatch, CEO of J.P. Morgan Asset Management, advises clients to diversify their holdings and stay invested.

Fintel reports that on February 6, 2025, JP Morgan upgraded their outlook for Altus Power (NYSE:AMPS) from Underweight to ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

Morgan Health launched a few months after J.P. Morgan, Amazon and Berkshire Hathaway disbanded their Haven joint venture.

From the impact of the new Trump Administration on research and development to advancements in brain health, PBM reform, and ...

At the J.P. Morgan Healthcare Conference, the Biotech CEO Sisterhood assembled in Union Square to showcase the large group of ...

And there is, in fact, one other big question hanging over the minds of professional investors like Bob Michele, J.P. Morgan ...